Net Income

A regulatory filing shows hedge fund Balyasny's active trading in Avadel Pharma, exposing a merger arbitrage strategy amid a fierce bidding war.

A landmark deal between a defense giant and a tech titan is set to revolutionize space operations. Here's why the future of national security is in the cloud.

The battery innovator secures fresh capital to scale its 'One-Pot' process. We analyze if this move signals a turning point for investors and the EV market.

A breakthrough stem cell study extends hope for stroke recovery. But a supplement brand is using it to sell 'detox' pills. We separate the facts from fiction.

Canada's top tire distributor is restructuring for global conquest. A deep dive into the new Touchette Corporation, the leaders driving it, and its M&A ambitions.

A major CRO presents 10 pivotal studies at the world's top blood disease meeting, revealing a strategy built on real-world data and collaborative innovation.

Lion Group is diversifying its crypto-heavy treasury with Bitcoin. Is this a savvy move in a cool market or a high-stakes bet for a volatile company?

SkinSpirit's new Princeton clinic isn't just an expansion; it's a strategic move in the booming medical aesthetics market. Here's why it matters.

Amid soaring uranium prices, Foremost Clean Energy deploys advanced geophysics in the Athabasca Basin. A deep dive into the strategy behind the search.

The medtech giant projects robust growth with an ambitious pipeline, but a high-stakes regulatory showdown over a key acquisition could redefine its future.